Renato V. LaRocca

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Egfrviii-expressing Glioblastoma, Neuro-oncology, Act Iv +10

Combined Immunochemotherapy With Reduced Whole-Brain Radiotherapy for Newly Diagnosed Primary CNS Lymphoma

Gaurav Shah, Joachim Yahalom, Denise D. Correa et al. · Journal of Clinical Oncology · 2007 · 397 citations · Full text

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma

Patrick Y. Wen, David A. Reardon, Terri S. Armstrong et al. · Clinical Cancer Research · 2019 · 259 citations · Full text

Characteristics of cell lines established from human gastric carcinoma.

Jae Gahb Park, Harold Frucht, Renato V. LaRocca et al. · PubMed · 1990 · 199 citations

Gene Amplification, Gastrointestinal Oncology, Malignant Disease +12

Randomized, Phase III Study of Weekly Paclitaxel in Combination With Carboplatin Versus Standard Every-3-Weeks Administration of Carboplatin and Paclitaxel for Patients With Previously Untreated Advanced Non–Small-Cell Lung Cancer

Chandra P. Belani, Suresh S. Ramalingam, Michael C. Perry et al. · Journal of Clinical Oncology · 2008 · 145 citations · Full text